查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602644

过敏治疗药物市场：按类型、治疗方法、分销管道划分 - 全球预测 2025-2030

Allergy Drugs Market by Type (Drug Allergy, Food Allergy, Inhaled Allergy), Treatment (Anti-allergy Drugs, Immunotherapy), Distribution Channels - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年过敏治疗药物市值为297.1亿美元，预计到2024年将达到322.1亿美元，复合年增长率为8.48%，到2030年将达到525.4亿美元。

我们的过敏药物涵盖范围广泛，用于治疗过敏反应的药物，例如抗组织胺、皮质类固醇、减充血剂和肾上腺素。这些药物治疗不同类型的过敏，包括季节性过敏、食物过敏和过敏性气喘。由于都市化、污染水平上升和饮食模式的改变，全世界过敏症盛行率不断上升，支持了对这些药物的需求。过敏药物（非处方药和处方药）用于缓解打喷嚏、搔痒和肿胀等症状。最终使用领域包括医院、诊所和家庭护理机构，并有多种给药形式支持，例如口服锭剂、滴鼻剂、吸入器和洗剂。

主要市场统计
基准年[2023] 297.1亿美元
预测年份 [2024] 322.1亿美元
预测年份 [2030] 525.4亿美元
复合年增长率（%） 8.48%

市场成长受到生物技术和基因研究不断进步等因素的影响，这些进步有助于更新、更有效的过敏治疗。此外，认知度和诊断率的提高也支持市场扩张。然而，市场面临长期使用这些药物带来的副作用、先进药物高成本以及新药认证严格的监管要求等挑战。拓展新兴市场存在潜在机会，这些市场的医疗基础设施正在改善，过敏意识也在增强。免疫疗法和生物製药的创新是公司可以重点研究的开拓领域。

公司可以根据遗传倾向探索针对特定类型过敏的个人化医疗方法。此外，输送机制还有创新的空间，包括更有效率和患者友善的给药方法，例如自动注射器和基于奈米技术的输送系统。过敏药物市场是一个竞争市场，学名药药和品牌药都在争夺市场占有率。专注于识别新过敏原和改善环境控制的研究工作可以进一步加强市场并为显着的业务成长提供途径。透过创新解决方案解决这些限制和挑战对于持续扩展市场至关重要。

市场动态：揭示快速发展的过敏药物市场的关键市场洞察

供需的动态交互作用正在改变过敏药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球过敏流行率不断上升
    • 加大过敏特异性药物的开发力道
    • 对非处方药的偏好日益增加
  • 市场限制因素
    • 对专利到期和学名药竞争的担忧
  • 市场机会
    • 免疫疗法简介和越来越多的给药方法
    • 消费者对食物过敏的认知不断增强
  • 市场挑战
    • 过敏药物替代品的可用性

波特五力：驾驭过敏药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解过敏药物市场的外部影响

外部宏观环境因素在影响过敏治疗药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解过敏治疗药物市场的竞争状况

过敏治疗药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵过敏治疗市场供应商的绩效评估

FPNV 定位矩阵是评估过敏治疗药物市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了过敏治疗药物市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，过敏治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球过敏盛行率不断上升
      • 加大过敏特异性药物的开发力道
      • 非处方药的普及率不断上升
    • 抑制因素
      • 对专利到期和学名药激烈竞争的担忧
    • 机会
      • 免疫疗法简介与给药方法的发展
      • 提高消费者对食品过敏的认知
    • 任务
      • 治疗过敏的替代药物的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章过敏治疗药物市场：依类型

  • 药物过敏
  • 食物过敏
  • 吸入过敏

第七章依治疗分类的过敏治疗药物市场

  • 抗过敏药
    • 抗组织胺药
    • 皮质类固醇
    • 白三烯抑制剂
  • 免疫疗法
    • 皮下免疫治疗 (SCIT)舌下免疫治疗 (SLIT)

第八章过敏治疗药物市场（依通路）

  • 医院药房
  • 网路药房
  • 零售药局/药局

第九章北美及南美过敏药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太过敏药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲过敏药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Allergy Therapeutics PLC
  • Astra Biotech GmbH
  • AstraZeneca PLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • HAL Allergy BV
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • LETI Pharma, SLU
  • Lupin Limited
  • Mylan NV by Viatris Inc.
  • Novartis AG
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • XOLAIR by F. Hoffmann-La Roche AG
Product Code: MRR-434CCDA051DF

The Allergy Drugs Market was valued at USD 29.71 billion in 2023, expected to reach USD 32.21 billion in 2024, and is projected to grow at a CAGR of 8.48%, to USD 52.54 billion by 2030.

The scope of allergy drugs encompasses a wide range of medications used to treat allergic reactions, including antihistamines, corticosteroids, decongestants, and epinephrine, among others. These drugs cater to various types of allergies such as seasonal allergies, food allergies, and allergic asthma. The necessity of these medications is underscored by the rising prevalence of allergies globally, driven by urbanization, increased pollution levels, and changing dietary patterns. In terms of application, allergy drugs are used in both over-the-counter and prescription forms to relieve symptoms like sneezing, itching, and swelling. End-use sectors include hospitals, clinics, and homecare settings, supported by a variety of delivery forms such as oral tablets, nasal sprays, inhalers, and lotions.

KEY MARKET STATISTICS
Base Year [2023] USD 29.71 billion
Estimated Year [2024] USD 32.21 billion
Forecast Year [2030] USD 52.54 billion
CAGR (%) 8.48%

Market growth is influenced by factors like continuous advancements in biotechnology and genetic research, which contribute to newer and more effective allergy treatments. Additionally, growing awareness and diagnosis rates further enhance market expansion. However, the market faces challenges such as side effects associated with long-term usage of these drugs, high costs of advanced medications, and stringent regulatory requirements for new drug approval. Potential opportunities exist in expanding into emerging markets where healthcare infrastructures are improving and awareness around allergies is rising. Innovations in immunotherapy and biologic drugs represent untapped areas where companies could focus research efforts.

Companies could explore personalized medicine approaches to target specific types of allergies based on genetic predispositions. Additionally, there is room for innovation in delivery mechanisms, such as more efficient and patient-friendly administration methods like auto-injectors or nanotechnology-based delivery systems. The nature of the allergy drugs market is competitive, with both generic and branded drugs vying for market share. Initiatives in research focused on identifying new allergens and improving environmental controls could further bolster the market and provide avenues for significant business growth. Addressing these limitations and challenges with innovative solutions is crucial for continued market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Drugs Market

The Allergy Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of allergy globally
    • Increasing development of allergy-specific drugs
    • Rise in prevalence towards over the counter drugs
  • Market Restraints
    • Concerns over patent expiration and extensive competition from generic drugs
  • Market Opportunities
    • Introduction of immunotherapy and development of increasing ways of administration
    • Rising consumer awareness on food allergies
  • Market Challenges
    • Availability of alternative drugs for allergy

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Drugs Market

A detailed market share analysis in the Allergy Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Drugs Market

A strategic analysis of the Allergy Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Drugs Market, highlighting leading vendors and their innovative profiles. These include Allergy Therapeutics PLC, Astra Biotech GmbH, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LETI Pharma, S.L.U., Lupin Limited, Mylan N.V. by Viatris Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., and XOLAIR by F. Hoffmann-La Roche AG.

Market Segmentation & Coverage

This research report categorizes the Allergy Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Drug Allergy, Food Allergy, and Inhaled Allergy.
  • Based on Treatment, market is studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs is further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy is further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).
  • Based on Distribution Channels, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of allergy globally
      • 5.1.1.2. Increasing development of allergy-specific drugs
      • 5.1.1.3. Rise in prevalence towards over the counter drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
      • 5.1.3.2. Rising consumer awareness on food allergies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative drugs for allergy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Allergy Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Drug Allergy
  • 6.3. Food Allergy
  • 6.4. Inhaled Allergy

7. Allergy Drugs Market, by Treatment

  • 7.1. Introduction
  • 7.2. Anti-allergy Drugs
    • 7.2.1. Antihistamines
    • 7.2.2. Corticosteroids
    • 7.2.3. Leukotriene Inhibitors
  • 7.3. Immunotherapy
    • 7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)

8. Allergy Drugs Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies & Drug Stores

9. Americas Allergy Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Allergy Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Allergy Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allergy Therapeutics PLC
  • 2. Astra Biotech GmbH
  • 3. AstraZeneca PLC
  • 4. Bayer AG
  • 5. GlaxoSmithKline PLC
  • 6. HAL Allergy B.V.
  • 7. Hikma Pharmaceuticals PLC
  • 8. Johnson & Johnson Services, Inc.
  • 9. LETI Pharma, S.L.U.
  • 10. Lupin Limited
  • 11. Mylan N.V. by Viatris Inc.
  • 12. Novartis AG
  • 13. Sanofi SA
  • 14. Teva Pharmaceutical Industries Ltd.
  • 15. XOLAIR by F. Hoffmann-La Roche AG

LIST OF FIGURES

  • FIGURE 1. ALLERGY DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGY DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALLERGY DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGY DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 233. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023